Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jean Philippe Torre"'
Autor:
Pierre Czernichow, Marie-Pierre Tavolacci, Jean Godart, V. Josset, Jean Philippe Torre, Véronique Merle, Joël Ladner, Karine Anselme, Vanessa Van Rossem-Magnani, Alain Libert
Publikováno v:
Gastroentérologie Clinique et Biologique. 28:351-357
Summary Hepatitis C viral infection (HCV) is a frequent and severe disease; screening strategies to-date remain insufficient. Objective To assess the efficiency of HCV screening of high-risk groups among patients consulting general practitioners. Met
Autor:
Christophe Doddoli, Julien Mancini, François Roux, Céline Gimenez, Jean-Pierre Kleisbauer, L. Greillier, Jean-Philippe Torre, Fabrice Barlesi
Publikováno v:
Respiratory Medicine. 98:357-362
Objective: To assess the value of Cyfra 21-1, carcino-embryonic antigen (CEA) and neuron-specific enolase (NSE) combined, all three together as prognostic factors in advanced stage non-small cell lung cancer (NSCLC) patients.Patients and methods: Ser
Autor:
Pierre Fuentes, Jean-Pierre Kleisbauer, Pascal Thomas, Roger Giudicelli, Fabrice Barlesi, Jean-Philippe Torre, Bruno Chetaille, Christophe Doddoli
Publikováno v:
Interactive Cardiovascular and Thoracic Surgery. 2:558-562
Regarding persisting controversies about neoadjuvant treatment (NT), we studied the impact of neoadjuvant therapy in daily practice. Patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) resected after NT were eligible. Data on preoperative
Autor:
Fabricc Barlesi, Jean-Philippe Torre, Olivier Chinot, Dominique Fiesehi, Jean-Charles Dufour, Marius Ficschi
Publikováno v:
Informatique et Santé ISBN: 9782287993046
Medical decision making and health care management is more and more a multidisciplinary approach especially in the field of oncology. Multidisciplinary meetings have to be supported in order to improve decisions taken and patients care. To meet this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e833786bd6f3c52493d7b06114d85fc
https://doi.org/10.1007/978-2-287-99305-3_19
https://doi.org/10.1007/978-2-287-99305-3_19
Autor:
Fabrice Barlesi, Pascal Thomas, David P. Breen, Christophe Doddoli, Jean-Philippe Torre, Myriam Zemerli, Philippe Astoul
Publikováno v:
Clinical lung cancer. 8(5)
Elderly patients now represent a bigger proportion of patients with non-small-cell lung cancer (NSCLC). However, data from clinical trials are limited for this age group, and the elderly are often excluded from optimal treatment for several reasons,
Autor:
Pierre Fuentes, Jean-Philippe Torre, Roger Giudicelli, Philippe Astoul, Christophe Doddoli, Fabrice Barlesi, Pascal Thomas
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 28(4)
Objective: Induction Therapy (IT) before surgery emerged as a widely used strategy for IIIAN2 and selected IIIB NSCLC patients. However, IT is associated with a possible increase in postoperative complications. Consequently, selection of patients wit
Autor:
Christophe Doddoli, Olivier Durieux, Fabrice Barlesi, L. Greillier, Céline Gimenez, Jean-Pierre Kleisbauer, Jean-Philippe Torre
Publikováno v:
Respiration; international review of thoracic diseases. 71(2)
Background: Stenting is a relatively new option in the management of superior vena cava obstruction (SVCO), but available data often concern non-malignant and/or various malignant diseases. Objective: The aim of this study was to assess the efficacy
Publikováno v:
Archives of Surgery. 137:493-493